Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation

Brian F. Gage, Amy D. Waterman, William Shannon, Michael Boechler, Michael W. Rich, Martha J. Radford

Research output: Contribution to journalArticlepeer-review

4351 Scopus citations


Context: Patients who have atrial fibrillation (AF) have an increased risk of stroke, but their absolute rate of stroke depends on age and comorbid conditions. Objective: To assess the predictive value of classification schemes that estimate stroke risk in patients with AF. Design, Setting, and Patients: Two existing classification schemes were combined into a new stroke-risk scheme, the CHADS2 index, and all 3 classification schemes were validated. The CHADS2 was formed by assigning 1 point each for the presence of congestive heart failure, hypertension, age 75 years or older, and diabetes mellitus and by assigning 2 points for history of stroke or transient ischemic attack. Data from peer review organizations representing 7 states were used to assemble a National Registry of AF (NRAF) consisting of 1733 Medicare beneficiaries aged 65 to 95 years who had nonrheumatic AF and were not prescribed warfarin at hospital discharge. Main Outcome Measure: Hospitalization for ischemic stroke, determined by Medicare claims data. Results: During 2121 patient-years of follow-up, 94 patients were readmitted to the hospital for ischemic stroke (stroke rate, 4.4 per 100 patient-years). As indicated by a c statistic greater than 0.5, the 2 existing classification schemes predicted stroke better than chance: c of 0.68 (95% confidence interval [CI], 0.65-0.71) for the scheme developed by the Atrial Fibrillation Investigators (AFI) and c of 0.74 (95% CI, 0.71-0.76) for the Stroke Prevention in Atrial Fibrillation (SPAF) III scheme. However, with a c statistic of 0.82 (95% CI, 0.80-0.84), the CHADS2 index was the most accurate predictor of stroke. The stroke rate per 100 patient-years without antithrombotic therapy increased by a factor of 1.5 (95% CI, 1.3-1.7) for each 1 -point increase in the CHADS2 score: 1.9 (95% CI, 1.2-3.0) for a score of 0; 2.8 (95% CI, 2.0-3.8) for 1; 4.0 (95% CI, 3.1-5.1) for 2; 5.9 (95% CI, 4.6-7.3) for 3; 8.5 (95% CI, 6.3-11.1) for 4; 12.5 (95% CI, 8.2-17.5) for 5; and 18.2 (95% CI, 10.5-27.4)for 6. Conclusion: The 2 existing classification schemes and especially a new stroke risk index, CHADS2, can quantify risk of stroke for patients who have AF and may aid in selection of antithrombotic therapy.

Original languageEnglish (US)
Pages (from-to)2864-2870
Number of pages7
JournalJournal of the American Medical Association
Issue number22
StatePublished - Jun 13 2001

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation'. Together they form a unique fingerprint.

Cite this